SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012562
Filing Date
2019-08-14
Accepted
2019-08-14 16:30:33
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 645740
2 ex31-1.htm EX-31.1 17149
3 ex31-2.htm EX-31.2 17174
4 ex32-1.htm EX-32.1 7763
5 ex32-2.htm EX-32.2 7750
  Complete submission text file 0001493152-19-012562.txt   4703507

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rspi-20190630.xml EX-101.INS 987534
7 XBRL SCHEMA FILE rspi-20190630.xsd EX-101.SCH 69844
8 XBRL CALCULATION FILE rspi-20190630_cal.xml EX-101.CAL 44527
9 XBRL DEFINITION FILE rspi-20190630_def.xml EX-101.DEF 207496
10 XBRL LABEL FILE rspi-20190630_lab.xml EX-101.LAB 421367
11 XBRL PRESENTATION FILE rspi-20190630_pre.xml EX-101.PRE 280887
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 191026901
SIC: 2834 Pharmaceutical Preparations